These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24714503)

  • 1. Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: a survey of health care providers.
    Madden NA; Jones GL; Kalpatthi R; Woods G
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e382-6. PubMed ID: 24714503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.
    Zumberg MS; Reddy S; Boyette RL; Schwartz RJ; Konrad TR; Lottenberg R
    Am J Hematol; 2005 Jun; 79(2):107-13. PubMed ID: 15929107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children with HbSβ
    Day ME; Rodeghier M; DeBaun MR
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27352. PubMed ID: 30094930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
    Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea or chronic exchange transfusions in patients with sickle cell disease: role of transcranial Doppler ultrasound in stroke prophylaxis.
    Suliman H; Wali Y; Al Saadoon M; Zechariah M; William RR; Gujjar A; Pathare A
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):42-4. PubMed ID: 19125086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza A; de Bisotti R; Sumoza D; Fairbanks V
    Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
    Mack AK; Thompson AA
    J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia.
    Champlin G; Hwang SN; Heitzer A; Ding J; Jacola L; Estepp JH; Wang W; Ataga KI; Owens CL; Newman J; King AA; Davis R; Kang G; Hankins JS
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2473-2479. PubMed ID: 34407676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.
    García-Morin M; Bardón-Cancho EJ; Beléndez C; Dulín E; Blanco-Soto P; Puertas-López C; Prieto-Medina M; Cervera-Bravo Á; Llorente-Otones L; Pérez-Alonso V; San-Román S; Vecilla-Rivelles C; López-Rubio M; Sebastián E; Bellón JM; Cela E
    Ann Hematol; 2024 Feb; 103(2):373-383. PubMed ID: 37980280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.
    Lanzkron S; Haywood C; Hassell KL; Rand C
    J Natl Med Assoc; 2008 Aug; 100(8):968-73. PubMed ID: 18717150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children.
    Brousseau DC; Richardson T; Hall M; Ellison AM; Shah SS; Raphael JL; Bundy DG; Arnold S
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31227564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis.
    Houwing ME; Grohssteiner RL; Dremmen MHG; Atiq F; Bramer WM; de Pagter APJ; Zwaan CM; White TJH; Vernooij MW; Cnossen MH
    BMC Med; 2020 Dec; 18(1):393. PubMed ID: 33349253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke in patients with sickle cell disease.
    Webb J; Kwiatkowski JL
    Expert Rev Hematol; 2013 Jun; 6(3):301-16. PubMed ID: 23782084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
    Ware RE; Zimmerman SA; Sylvestre PB; Mortier NA; Davis JS; Treem WR; Schultz WH
    J Pediatr; 2004 Sep; 145(3):346-52. PubMed ID: 15343189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases].
    Mellouli F; Chouaibi S; Dhouib N; Ouederni M; Ben Khaled M; Abbes S; Bejaoui M
    Tunis Med; 2013; 91(8-9):544-50. PubMed ID: 24227514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
    Creary SE; Gladwin MT; Byrne M; Hildesheim M; Krishnamurti L
    Pediatr Blood Cancer; 2014 Jun; 61(6):1068-73. PubMed ID: 24436121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.
    Kassim AA; DeBaun MR
    Expert Opin Pharmacother; 2014 Feb; 15(3):325-36. PubMed ID: 24392871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.